Review: the role of hyperthermia in treating pancreatic tumors.
There is only marginal improvement in outcome of treating pancreatic cancer in the last two decades. Time to open up and have a fresh look at complementary adjuvant treatment options. Hyperthermia may be one such option. Hyperthermic intraperitoneal chemotherapy (HIPEC) predominantly as a intrasurgical procedure has already proved its justification. Non-invasive loco regional hyperthermia as complement to either chemo or radiation has not yet reached a comparable status of evidence. However the potential to eventually grow into such evidence is already clearly observable. This review presents the various methodologies available for hyperthermia, covers the initial clinical data that has been published and gives an outlook to what can be expected in the next 2-3 years to come. Hyperthermia has the potential to significantly prolong life expectancies and this while maintaining a satisfying quality of life!
Research & Development Celsius42+, Mannheim, Germany.
Martin
M
Roesch
Oncology, Paracelsus Klinik, Zurich-Richterswil, Switzerland.
Boris
B
Mueller-Huebenthal
Adjuvant heat treatment; Hyperthermia; Palliative pain reduction; Pancreatic cancer